| Design and synthesis of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs–CAIs) for the treatment of rheumatoid arthritis S Bua, L Di Cesare Mannelli, D Vullo, C Ghelardini, G Bartolucci, ... Journal of medicinal chemistry 60 (3), 1159-1170, 2017 | 127 | 2017 |
| Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC … WM Eldehna, MF Abo-Ashour, A Nocentini, RS El-Haggar, S Bua, ... European journal of medicinal chemistry 162, 147-160, 2019 | 89 | 2019 |
| Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand/isoform matching and selectivity of action A Bonardi, A Nocentini, S Bua, J Combs, C Lomelino, J Andring, ... Journal of medicinal chemistry 63 (13), 7422-7444, 2020 | 82 | 2020 |
| 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico … MF Abo-Ashour, WM Eldehna, A Nocentini, A Bonardi, S Bua, HS Ibrahim, ... European Journal of Medicinal Chemistry 184, 111768, 2019 | 67 | 2019 |
| Structured optical materials controlled by light S Nocentini, D Martella, C Parmeggiani, S Zanotto, DS Wiersma Advanced Optical Materials 6 (15), 1800167, 2018 | 64 | 2018 |
| Discovery of new sulfonamide carbonic anhydrase IX inhibitors incorporating nitrogenous bases A Nocentini, S Bua, CL Lomelino, R McKenna, M Menicatti, G Bartolucci, ... ACS medicinal chemistry letters 8 (12), 1314-1319, 2017 | 64 | 2017 |
| Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and … WM Eldehna, GH Al-Ansary, S Bua, A Nocentini, P Gratteri, A Altoukhy, ... European Journal of Medicinal Chemistry 127, 521-530, 2017 | 64 | 2017 |
| Design and synthesis of novel 1, 3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors N Lolak, S Akocak, S Bua, M Koca, CT Supuran Bioorganic chemistry 77, 542-547, 2018 | 60 | 2018 |
| Discovery of β-adrenergic receptors blocker–carbonic anhydrase inhibitor hybrids for multitargeted antiglaucoma therapy A Nocentini, M Ceruso, S Bua, CL Lomelino, JT Andring, R McKenna, ... Journal of Medicinal Chemistry 61 (12), 5380-5394, 2018 | 56 | 2018 |
| Discovery of new ureido benzenesulfonamides incorporating 1, 3, 5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors N Lolak, S Akocak, S Bua, RKK Sanku, CT Supuran Bioorganic & medicinal chemistry 27 (8), 1588-1594, 2019 | 55 | 2019 |
| Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies MF Abo-Ashour, WM Eldehna, A Nocentini, HS Ibrahim, S Bua, ... European Journal of Medicinal Chemistry 157, 28-36, 2018 | 54 | 2018 |
| Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1, 3, 5-triazine moieties as potent carbonic anhydrase IX inhibitors N Lolak, S Akocak, S Bua, CT Supuran Bioorganic Chemistry 82, 117-122, 2019 | 53 | 2019 |
| Design and synthesis of novel benzenesulfonamide containing 1, 2, 3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors R Kumar, L Vats, S Bua, CT Supuran, PK Sharma European journal of medicinal chemistry 155, 545-551, 2018 | 53 | 2018 |
| Discovery of novel 1, 3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors S Akocak, N Lolak, S Bua, CT Supuran Journal of Enzyme Inhibition and Medicinal Chemistry 33 (1), 1575-1580, 2018 | 52 | 2018 |
| Novel synthesized SLC-0111 thiazole and thiadiazole analogues: Determination of their carbonic anhydrase inhibitory activity and molecular modeling studies MF Abo-Ashour, WM Eldehna, A Nocentini, HS Ibrahim, S Bua, ... Bioorganic Chemistry 87, 794-802, 2019 | 51 | 2019 |
| 2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies … N Chiaramonte, S Bua, M Ferraroni, A Nocentini, A Bonardi, G Bartolucci, ... European Journal of Medicinal Chemistry 151, 363-375, 2018 | 47 | 2018 |
| Benzenesulfonamide bearing imidazothiadiazole and thiazolotriazole scaffolds as potent tumor associated human carbonic anhydrase IX and XII inhibitors R Kumar, S Bua, S Ram, S Del Prete, C Capasso, CT Supuran, ... Bioorganic & Medicinal Chemistry 25 (3), 1286-1293, 2017 | 46 | 2017 |
| Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII … HI Gul, C Yamali, M Bulbuller, PB Kirmizibayrak, M Gul, A Angeli, S Bua, ... Bioorganic chemistry 78, 290-297, 2018 | 44 | 2018 |
| Inhibition of Malassezia globosa carbonic anhydrase with phenols YE Heravi, S Bua, A Nocentini, S Del Prete, AA Saboury, H Sereshti, ... Bioorganic & medicinal chemistry 25 (9), 2577-2582, 2017 | 44 | 2017 |
| Synthesis and biological evaluation of benzenesulphonamide-bearing 1, 4, 5-trisubstituted-1, 2, 3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory … R Kumar, V Sharma, S Bua, CT Supuran, PK Sharma Journal of Enzyme Inhibition and Medicinal Chemistry 32 (1), 1187-1194, 2017 | 44 | 2017 |
Alessio NocentiniUniversità degli Studi di Firenze, NEUROFARBA Dept.Verified email at unifi.it
